China’s Regulatory Update Creates New Opportunities for NMN in Cosmetic Formulations
The supply chain for premium NMN cosmetic ingredients has reached an important regulatory milestone in China’s cosmetics industry.
Following the completion of its three-year safety monitoring period, NMN has been included in China’s Inventory of Existing Cosmetic Ingredients (IECIC) II, marking an important transition from cosmetic new ingredient registration and safety monitoring to broader industry use within the applicable cosmetic framework.
For cosmetic brands, formulators and ingredient suppliers, this change represents more than a regulatory update. It signals a new stage for the commercialization of NMN in topical cosmetic applications and places greater emphasis on ingredient quality, impurity control, formulation stability, technical support and compliance.
For the NMN ingredient supply chain, the competitive landscape is also evolving—from a model centered primarily on qualification and access toward one increasingly driven by technology, quality consistency, manufacturing capability and formulation support.
What Does NMN’s Inclusion in IECIC II Mean?
Before its inclusion in the existing cosmetic ingredient inventory, NMN was subject to the regulatory framework for cosmetic new ingredients, including a three-year safety monitoring period.
With the completion of this monitoring period and its inclusion in IECIC II, the use of NMN in cosmetic products is now positioned within the established framework for existing cosmetic ingredients, subject to applicable regulations and product requirements.
This development can help reduce certain entry barriers for cosmetic brands considering NMN-based formulations.
At the same time, it does not mean that all requirements disappear.
The focus of industry competition is likely to shift toward the quality and safety of the ingredient, manufacturing consistency, formulation compatibility and substantiation of cosmetic claims.
In other words, the market is moving from:
For brands and formulators, this makes the selection of a reliable NMN ingredient supplier increasingly important.
The New Competitive Landscape for NMN Cosmetic Ingredients
The regulatory transition creates opportunities for more cosmetic brands to explore NMN, but it also raises the importance of upstream ingredient quality.
For NMN suppliers, several capabilities are becoming increasingly important.
1. Ingredient Quality and Impurity Control
Cosmetic formulations require consistent raw-material quality and appropriate control of impurities and degradation-related substances.
As NMN enters broader cosmetic applications, suppliers with established analytical methods, quality-control systems and batch consistency will be better positioned to support brands developing commercial products.
2. Manufacturing Stability
For brands moving from laboratory testing to commercial production, consistency between samples, pilot batches and large-scale production is critical.
A reliable NMN supplier needs to demonstrate not only high purity in individual samples, but also stable quality across production batches and scalable manufacturing processes.
3. Formulation Compatibility
NMN has specific physicochemical characteristics that need to be considered during cosmetic formulation.
Its stability can be affected by factors such as temperature, pH, light exposure and the surrounding formulation environment. Therefore, simply adding NMN to a formula is not sufficient. Appropriate formulation design and process control are important for maintaining ingredient quality throughout product development.
4. Technical and Regulatory Support
As more brands begin exploring NMN cosmetic products, ingredient suppliers will increasingly be expected to provide more than a specification sheet.
Technical documentation, quality data, formulation communication and project-specific support can help brands reduce development uncertainty and accelerate product development.
Understanding the Cosmetic Potential of Topical NMN
NMN has attracted significant attention in the anti-aging field because of its relationship with NAD+ metabolism and cellular energy pathways.
However, topical NMN should not simply be treated as a cosmetic equivalent of oral NMN.
Topical and oral applications involve different delivery environments and different levels of scientific evidence.
NMN is a highly polar, water-soluble molecule, and its ability to cross the skin barrier can be affected by the properties of the stratum corneum and the formulation system.
This means that the cosmetic value of NMN should be considered within the context of formulation science, delivery systems and appropriate product design, rather than through exaggerated claims.
At the same time, emerging research has continued to investigate the potential role of NMN in skin-related biological processes.
Studies have reported potential relationships between NMN and mechanisms associated with oxidative stress, skin barrier function, mitochondrial activity and UV-induced skin damage.
These findings provide a scientific basis for further exploration of NMN in cosmetic formulations, while continued research and appropriate product-specific substantiation remain important.
From “Ingredient Stacking” to Systematic Formulation Innovation
The inclusion of NMN in IECIC II may encourage more brands to explore NMN-based cosmetic products.
However, simply increasing the concentration of a single active ingredient is unlikely to become a sustainable competitive strategy.
Instead, the next stage of NMN cosmetic development is likely to focus on systematic formulation design and complementary ingredient combinations.
1. High-End Anti-Aging Formulations
NMN may be explored in combination with complementary cosmetic ingredients targeting different biological pathways.
Potential formulation concepts may combine NMN with ingredients such as L-Ergothioneine, PQQ, ceramides and vitamin E, depending on the formulation objective and applicable regulatory requirements.
Such approaches can help brands develop broader concepts around cellular nutrition, antioxidant protection and skin barrier support, rather than relying on a single-ingredient positioning.
2. Targeted Skin-Care Applications
Another opportunity lies in developing products around specific skin-care scenarios. Potential directions include:
The key is to connect the ingredient with an appropriate formulation strategy and scientifically supportable cosmetic claims.
3. Premium Cosmetic Products
NMN’s positioning as an emerging active ingredient may also create opportunities for premium cosmetic formats, including:
For premium brands, the combination of ingredient quality, formulation technology, scientific substantiation and compliant communication can become more important than simply highlighting the presence of NMN.
What Will Define the Next Generation of NMN Ingredient Suppliers?
As regulatory access becomes less of a differentiating factor, the NMN supply chain is entering a new stage. The traditional competitive model can be summarized as:
This shift favors ingredient manufacturers with strong upstream capabilities and integrated technical resources. For cosmetic brands, choosing an NMN supplier should therefore involve more than comparing purity specifications. Important considerations may include:
Hygieia Biotech’s NMN Capabilities
Hygieia Biotech is focused on the development and commercialization of biosynthetic active ingredients, with NMN as one of its key anti-aging ingredient platforms.
Through its Zymevolver® strain engineering and enzyme evolution platform, Hygieia Biotech has developed an enzymatic approach to NMN production and established integrated capabilities covering research, process development, manufacturing and quality control.
The company has participated in the development of multiple NMN-related industry standards, including standards covering NMN cosmetic raw materials, NMN purity and content determination, and quality standards for biologically produced NMN used in import and export applications.
These experiences provide a technical foundation for supporting customers evaluating NMN for cosmetic ingredient applications.
Integrated Manufacturing and Quality Control
For cosmetic applications, ingredient quality is not defined solely by a nominal purity value. Hygieia Biotech focuses on multiple aspects of NMN quality management, including:
Enzymatic Production Technology
Hygieia Biotech applies its proprietary enzyme engineering platform to support the development of an enzymatic NMN production process with controlled upstream manufacturing.
Impurity and Process Control
Cosmetic applications place increasing emphasis on impurity profiles and ingredient stability. Hygieia Biotech has developed purification and quality-control processes designed to address the specific requirements associated with NMN ingredient production.
Scalable Manufacturing
Commercial-scale production requires stable process replication from laboratory development through pilot production and large-scale manufacturing. Hygieia Biotech has established standardized manufacturing capabilities designed to support commercial B2B ingredient supply.
Technical Support for Product Development
Rather than focusing solely on raw-material supply, Hygieia Biotech works with B2B customers on ingredient selection, formulation discussions, quality documentation and product-development requirements.
This integrated approach can help brands reduce development uncertainty when introducing NMN into new cosmetic concepts.
NMN as Part of a Broader Active Ingredient Portfolio
Hygieia Biotech does not view NMN as an isolated ingredient.
The company has developed a broader portfolio of high-value active ingredients covering areas such as healthy aging, cellular health, women’s wellness and sports nutrition.
Its active ingredient portfolio includes products such as NMN, Calcium-AKG, L-Ergothioneine, PQQ and Urolithin A, enabling customers to explore ingredient combinations and differentiated formulation concepts based on their product objectives.
For brands developing premium anti-aging products, this broader portfolio can provide opportunities to evaluate multi-ingredient formulation strategies rather than relying on a single active ingredient.
What Does This Mean for Cosmetic Brands?
The inclusion of NMN in China’s existing cosmetic ingredient framework creates a new opportunity for cosmetic brands, but the opportunity should be approached strategically.
The regulatory change may lower certain barriers to exploring NMN, but it does not eliminate the need for:
Brands entering the NMN cosmetic market should therefore consider the entire product-development process—from ingredient selection and quality verification to formulation testing, manufacturing and final cosmetic claims.
The next stage of NMN commercialization will likely belong to companies that can combine ingredient technology, formulation expertise and responsible scientific communication.
From Regulatory Milestone to Commercial Opportunity
NMN’s inclusion in China’s Inventory of Existing Cosmetic Ingredients represents an important milestone for the development of NMN in topical cosmetic applications.
The significance of this change goes beyond regulatory access.
It marks a transition toward a more mature market in which ingredient quality, manufacturing technology, formulation capability and scientific substantiation will increasingly determine the competitiveness of both suppliers and brands.
For NMN ingredient manufacturers, the opportunity is no longer simply to supply a high-purity powder.
The greater opportunity is to provide stable, reliable and technically supported ingredient solutions that help brands translate an emerging active ingredient into commercially viable cosmetic products.
Hygieia Biotech will continue to focus on biosynthetic active ingredients and integrated technical capabilities, supporting global customers exploring NMN and other high-value nutraceutical and cosmetic ingredients.
If you are evaluating NMN Powder for cosmetic ingredient sourcing, formulation development or commercial product projects, our team welcomes the opportunity to discuss your requirements.
The next stage of NMN commercialization will likely belong to companies that can combine ingredient technology, formulation expertise and responsible scientific communication.
Ready to Formulate with NMN?
References
- Permeation of Nicotinamide Mononucleotide (NMN) in an Artificial Membrane as a Cosmetic Skin Permeability Test Model. Journal of Cosmetic Dermatology, 2026.
- Kim S. J., et al. β-Nicotinamide Mononucleotide Enhances Skin Barrier Function and Attenuates UVB-Induced Photoaging in Mice. Antioxidants, 2025, 14(12):1424.
- Gao W., et al. β-Nicotinamide mononucleotide blocks UVB-induced collagen reduction via regulation of ROS/MAPK/AP1 and stimulation of mitochondrial proline biosynthesis. Journal of Photochemistry and Photobiology B: Biology, 2025.
- Distinctive Gene Expression Profiles and Biological Responses of Skin Fibroblasts to Nicotinamide Mononucleotide: Implications for Longevity Effects on Skin. International Journal of Molecular Sciences, 2025.
- Gao Biao, Long Yan, Peng Chunmei, et al. “Safety and Efficacy Evaluation of β-Nicotinamide Mononucleotide in Cosmetic Applications.” Detergents & Cosmetics, 2026.
- Sabbagh F., Kim B. S. Elastic cationic liposomal nanogels: a novel platform for topical nicotinamide mononucleotide delivery. Journal of Liposome Research, 2025.